[Comparative effectiveness of immunomodulators in the therapy of bronchopulmonary diseases].
One hundred and fifty-one patients with bronchopulmonary diseases were examined and it was shown that they had secondary immune deficiency mainly in the T-cells which could not be recovered with the routine therapeutic agents. The use of hemodez, levamisole or sodium nucleinate in the combined therapy promoted correction of the immune deficiency and increased the treatment efficacy. Sodium nucleinate proved to be the most efficient.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D001249:Asthma / Q000188:drug therapy / Q000276:immunology; D001982:Bronchial Diseases / Q000188:drug therapy* / Q000276:immunology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use; D008171:Lung Diseases / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D009696:Nucleic Acids / Q000627:therapeutic use; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D011205:Povidone / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D009696:Nucleic Acids; D007978:Levamisole; C007918:hemodes; C013683:sodium nucleinate; D011205:Povidone
Sravnitel'naia éffektivnost' nekotorykh immunomoduliatorov v terapii bronkholegochnykh zabolevaniĭ.